Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES WOCKHARDT ALKEM LABORATORIES/
WOCKHARDT
 
P/E (TTM) x 29.3 -10.6 - View Chart
P/BV x 4.5 1.0 468.0% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 ALKEM LABORATORIES   WOCKHARDT
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-22
WOCKHARDT
Mar-22
ALKEM LABORATORIES/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs4,068805 505.6%   
Low Rs2,671253 1,055.0%   
Sales per share (Unadj.) Rs889.4224.3 396.6%  
Earnings per share (Unadj.) Rs140.5-19.4 -725.5%  
Cash flow per share (Unadj.) Rs166.0-2.2 -7,469.4%  
Dividends per share (Unadj.) Rs34.000-  
Avg Dividend yield %1.00-  
Book value per share (Unadj.) Rs722.4266.0 271.6%  
Shares outstanding (eoy) m119.57144.03 83.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.82.4 160.7%   
Avg P/E ratio x24.0-27.3 -87.8%  
P/CF ratio (eoy) x20.3-238.0 -8.5%  
Price / Book Value ratio x4.72.0 234.6%  
Dividend payout %24.20-   
Avg Mkt Cap Rs m402,86876,168 528.9%   
No. of employees `000NANA-   
Total wages/salary Rs m19,6277,490 262.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m106,34232,300 329.2%  
Other income Rs m1,627200 813.3%   
Total revenues Rs m107,96832,500 332.2%   
Gross profit Rs m20,3801,150 1,772.1%  
Depreciation Rs m3,0402,470 123.1%   
Interest Rs m5242,990 17.5%   
Profit before tax Rs m18,443-4,110 -448.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,640-1,320 -124.2%   
Profit after tax Rs m16,803-2,790 -602.3%  
Gross profit margin %19.23.6 538.3%  
Effective tax rate %8.932.1 27.7%   
Net profit margin %15.8-8.6 -182.9%  
BALANCE SHEET DATA
Current assets Rs m84,35425,890 325.8%   
Current liabilities Rs m48,05332,070 149.8%   
Net working cap to sales %34.1-19.1 -178.4%  
Current ratio x1.80.8 217.4%  
Inventory Days Days4231 134.1%  
Debtors Days Days6510 623.6%  
Net fixed assets Rs m43,24550,810 85.1%   
Share capital Rs m239720 33.2%   
"Free" reserves Rs m86,13437,590 229.1%   
Net worth Rs m86,37338,310 225.5%   
Long term debt Rs m943,550 2.6%   
Total assets Rs m127,59976,700 166.4%  
Interest coverage x36.2-0.4 -9,668.5%   
Debt to equity ratio x00.1 1.2%  
Sales to assets ratio x0.80.4 197.9%   
Return on assets %13.60.3 5,207.6%  
Return on equity %19.5-7.3 -267.1%  
Return on capital %21.9-2.7 -819.8%  
Exports to sales %18.70-   
Imports to sales %01.9 0.0%   
Exports (fob) Rs m19,924NA-   
Imports (cif) Rs mNA624 0.0%   
Fx inflow Rs m19,9242,263 880.6%   
Fx outflow Rs m3,911624 626.5%   
Net fx Rs m16,0131,638 977.4%   
CASH FLOW
From Operations Rs m11,1104,130 269.0%  
From Investments Rs m-14,351-2,010 714.0%  
From Financial Activity Rs m3,796-710 -534.6%  
Net Cashflow Rs m5801,380 42.0%  

Share Holding

Indian Promoters % 57.1 65.8 86.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 19.8 2.9 679.4%  
FIIs % 5.7 2.8 201.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.9 34.3 125.1%  
Shareholders   84,104 180,170 46.7%  
Pledged promoter(s) holding % 0.0 47.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    AUROBINDO PHARMA    LUPIN    


More on ALKEM LABORATORIES vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALKEM LABORATORIES vs Wockhardt Share Price Performance

Period ALKEM LABORATORIES Wockhardt S&P BSE HEALTHCARE
1-Day -0.50% -0.64% -0.46%
1-Month 11.09% 0.23% 0.65%
1-Year -17.79% -40.78% -13.70%
3-Year CAGR 19.17% -5.42% 20.93%
5-Year CAGR 12.21% -15.89% 10.98%

* Compound Annual Growth Rate

Here are more details on the ALKEM LABORATORIES share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of ALKEM LABORATORIES hold a 57.1% stake in the company. In case of Wockhardt the stake stands at 65.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALKEM LABORATORIES and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, ALKEM LABORATORIES paid a dividend of Rs 34.0 per share. This amounted to a Dividend Payout ratio of 24.2%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ALKEM LABORATORIES, and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

5 Reasons Why Sensex Plunged 1,021 Points Today(Closing)

After opening the day on a negative note, Indian share markets extended losses as the session progressed and ended deep in the red.